IL111029A - Esters of 4-hydroxyalkyl-indoline-2-helium - Google Patents

Esters of 4-hydroxyalkyl-indoline-2-helium

Info

Publication number
IL111029A
IL111029A IL11102991A IL11102991A IL111029A IL 111029 A IL111029 A IL 111029A IL 11102991 A IL11102991 A IL 11102991A IL 11102991 A IL11102991 A IL 11102991A IL 111029 A IL111029 A IL 111029A
Authority
IL
Israel
Prior art keywords
water
equiv
preparation
added
washed
Prior art date
Application number
IL11102991A
Other languages
English (en)
Hebrew (he)
Original Assignee
Smith Kline French Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smith Kline French Lab filed Critical Smith Kline French Lab
Publication of IL111029A publication Critical patent/IL111029A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C205/00—Compounds containing nitro groups bound to a carbon skeleton
    • C07C205/39—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by esterified hydroxy groups
    • C07C205/40—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by esterified hydroxy groups having nitro groups and esterified hydroxy groups bound to acyclic carbon atoms of the carbon skeleton
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C201/00—Preparation of esters of nitric or nitrous acid or of compounds containing nitro or nitroso groups bound to a carbon skeleton
    • C07C201/06—Preparation of nitro compounds
    • C07C201/12—Preparation of nitro compounds by reactions not involving the formation of nitro groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/76—Esters of carboxylic acids having a carboxyl group bound to a carbon atom of a six-membered aromatic ring
    • C07C69/78—Benzoic acid esters
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/32—Oxygen atoms
    • C07D209/34—Oxygen atoms in position 2

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Indole Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
IL11102991A 1990-04-17 1991-04-16 Esters of 4-hydroxyalkyl-indoline-2-helium IL111029A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB909008605A GB9008605D0 (en) 1990-04-17 1990-04-17 Process
IL9786791A IL97867A (en) 1990-04-17 1991-04-16 Process for making indolones and intermediates used in it

Publications (1)

Publication Number Publication Date
IL111029A true IL111029A (en) 1995-11-27

Family

ID=10674534

Family Applications (7)

Application Number Title Priority Date Filing Date
IL11102991A IL111029A (en) 1990-04-17 1991-04-16 Esters of 4-hydroxyalkyl-indoline-2-helium
IL9786791A IL97867A (en) 1990-04-17 1991-04-16 Process for making indolones and intermediates used in it
IL11102891A IL111028A (en) 1990-04-17 1991-04-16 4-Hydroxyalkyl- Indole-2-Onim
IL11103091A IL111030A (en) 1990-04-17 1991-04-16 Phenyl-alkyl alcohol esters are converted to position 2
IL11102994A IL111029A0 (en) 1990-04-17 1994-09-22 Intermediates to indolones
IL11103094A IL111030A0 (en) 1990-04-17 1994-09-22 Intermediates to indolones
IL11102894A IL111028A0 (en) 1990-04-17 1994-09-22 Intermediates to indolones

Family Applications After (6)

Application Number Title Priority Date Filing Date
IL9786791A IL97867A (en) 1990-04-17 1991-04-16 Process for making indolones and intermediates used in it
IL11102891A IL111028A (en) 1990-04-17 1991-04-16 4-Hydroxyalkyl- Indole-2-Onim
IL11103091A IL111030A (en) 1990-04-17 1991-04-16 Phenyl-alkyl alcohol esters are converted to position 2
IL11102994A IL111029A0 (en) 1990-04-17 1994-09-22 Intermediates to indolones
IL11103094A IL111030A0 (en) 1990-04-17 1994-09-22 Intermediates to indolones
IL11102894A IL111028A0 (en) 1990-04-17 1994-09-22 Intermediates to indolones

Country Status (29)

Country Link
US (1) US5336781A (fi)
EP (1) EP0526529B1 (fi)
JP (2) JP2788548B2 (fi)
KR (1) KR0180215B1 (fi)
CN (1) CN1027892C (fi)
AP (1) AP184A (fi)
AT (1) ATE144251T1 (fi)
AU (2) AU640006B2 (fi)
CA (1) CA2080221C (fi)
CY (1) CY1981A (fi)
DE (1) DE69122753T2 (fi)
DK (1) DK0526529T3 (fi)
ES (1) ES2094812T3 (fi)
FI (1) FI101148B (fi)
GB (1) GB9008605D0 (fi)
GR (1) GR3022261T3 (fi)
HK (1) HK3097A (fi)
HU (1) HU214822B (fi)
IE (1) IE911262A1 (fi)
IL (7) IL111029A (fi)
MA (1) MA22133A1 (fi)
MY (1) MY109628A (fi)
NO (2) NO178396C (fi)
NZ (1) NZ237819A (fi)
PL (1) PL166736B1 (fi)
PT (1) PT97375B (fi)
SA (1) SA91110352B1 (fi)
WO (1) WO1991016306A1 (fi)
ZA (1) ZA912782B (fi)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9008605D0 (en) * 1990-04-17 1990-06-13 Smith Kline French Lab Process
ES2137932T3 (es) * 1990-09-28 2000-01-01 Smithkline Beecham Corp Procedimiento para la preparacion de analogos de camptotecina solubles en agua, asi como los compuestos 10-hidroxi-11-alcoxi-6-camptotecina.
GB9300309D0 (en) * 1993-01-08 1993-03-03 Smithkline Beecham Plc Process
US6218421B1 (en) * 1999-07-01 2001-04-17 Smithkline Beecham P.L.C. Method of promoting smoking cessation
AR030557A1 (es) 2000-04-14 2003-08-27 Jagotec Ag Una tableta en multicapa de liberacion controlada y metodo de tratamiento
WO2005074387A2 (en) * 2003-12-30 2005-08-18 Sun Pharmaceutical Industries Limited Novel crystal forms of 4-[2-di-n-propylamino)ethyl]-2 (3h)- indolone hydrochloride
US7378439B2 (en) * 2004-01-20 2008-05-27 Usv, Ltd. Process for the preparation of 4-(2-dipropylaminoethyl)-1,3-dihydro-2H-indol-2-one hydrochloride
WO2005105741A1 (en) * 2004-02-11 2005-11-10 Sun Pharmaceutical Industries Limited Substantially pure 4-[2-(di-n-propylamino)ethyl]-2(3h)-indolone hydrochloride
WO2005080333A1 (en) * 2004-02-19 2005-09-01 Torrent Pharmaceuticals Ltd Process for purification of ropinirole
US20070254941A1 (en) * 2006-04-21 2007-11-01 Glenmark Pharmaceuticals Limited Subtantially pure ropinirole hydrochloride, polymorphic form of ropinirole and process for their preparation
CN103130704B (zh) * 2013-03-11 2019-03-22 上海奥博生物医药技术有限公司 一种制备4-(2-羟乙基)-1，3-二氢-2h-吲哚-2-酮的新方法
CN103145604A (zh) * 2013-03-19 2013-06-12 上海奥博生物医药技术有限公司 一种制备罗匹尼罗关键中间体的方法
CN105418482A (zh) * 2015-11-23 2016-03-23 东南大学 一种改进的盐酸罗匹尼罗的制备方法
CN108440376B (zh) * 2018-05-08 2020-06-05 中国科学院成都生物研究所 一种盐酸罗匹尼罗的制备方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1154976A (en) * 1967-02-21 1969-06-11 Pfizer Ltd N-Phenyl Indoline Derivatives
JPS53101333A (en) * 1977-02-14 1978-09-04 Sagami Chem Res Center 3-acyloxymethyl-3,4:5,6-diepoxycyclohexane-1,2-diol and
IT1171624B (it) * 1980-11-12 1987-06-10 Thomae Gmbh Dr K Indolinoni dotati di proprieta' farmaceutiche e procedimento per la loro produzione
US4588790A (en) * 1982-03-24 1986-05-13 Union Carbide Corporation Method for fluidized bed polymerization
US4452808A (en) * 1982-12-07 1984-06-05 Smithkline Beckman Corporation 4-Aminoalkyl-2(3H)-indolones
US4593033A (en) * 1985-04-24 1986-06-03 Merck & Co., Inc. Substituted indeno[2,1-c] pyridines useful as calcium channel blockers
GB8712073D0 (en) * 1987-05-21 1987-06-24 Smith Kline French Lab Medicament
GB8714371D0 (en) * 1987-06-19 1987-07-22 Smith Kline French Lab Process
FR2635104B1 (fr) * 1988-08-03 1992-04-30 Synthelabo Derives d'indolone, leur preparation et leur application en therapeutique
GB9008605D0 (en) * 1990-04-17 1990-06-13 Smith Kline French Lab Process

Also Published As

Publication number Publication date
ATE144251T1 (de) 1996-11-15
CA2080221A1 (en) 1991-10-18
ZA912782B (en) 1992-11-25
GR3022261T3 (en) 1997-04-30
CA2080221C (en) 2000-11-14
NO924028L (no) 1992-10-16
IL111030A (en) 1995-11-27
IL111028A (en) 1995-11-27
JPH05506029A (ja) 1993-09-02
CY1981A (en) 1997-09-05
PT97375A (pt) 1992-01-31
PL166736B1 (pl) 1995-06-30
IE911262A1 (en) 1991-10-23
GB9008605D0 (en) 1990-06-13
IL111030A0 (en) 1994-11-28
NO1999012I1 (no) 1999-06-18
AU3566993A (en) 1993-06-03
HU9203261D0 (en) 1992-12-28
WO1991016306A1 (en) 1991-10-31
NO924028D0 (no) 1992-10-16
EP0526529A1 (en) 1993-02-10
AP9100251A0 (en) 1991-04-30
HK3097A (en) 1997-01-10
IL111028A0 (en) 1994-11-28
IL97867A (en) 1995-11-27
AP184A (en) 1992-06-30
JP2788548B2 (ja) 1998-08-20
HU214822B (hu) 1998-06-29
IL97867A0 (en) 1992-06-21
FI924674A (fi) 1992-10-15
DK0526529T3 (da) 1996-11-18
AU7656291A (en) 1991-11-11
US5336781A (en) 1994-08-09
CN1027892C (zh) 1995-03-15
SA91110352B1 (ar) 2001-11-12
IL111029A0 (en) 1994-11-28
NO178396B (no) 1995-12-11
DE69122753D1 (de) 1996-11-21
CN1056686A (zh) 1991-12-04
FI101148B (fi) 1998-04-30
ES2094812T3 (es) 1997-02-01
PT97375B (pt) 1998-08-31
FI924674A0 (fi) 1992-10-15
HUT64742A (en) 1994-02-28
JPH10251205A (ja) 1998-09-22
KR0180215B1 (ko) 1999-03-20
NO178396C (no) 1996-03-20
NZ237819A (en) 1993-05-26
EP0526529B1 (en) 1996-10-16
MY109628A (en) 1997-03-31
AU646771B2 (en) 1994-03-03
MA22133A1 (fr) 1991-12-31
JP3044013B2 (ja) 2000-05-22
DE69122753T2 (de) 1997-05-07
AU640006B2 (en) 1993-08-12

Similar Documents

Publication Publication Date Title
KR101461291B1 (ko) 약학적 활성 화합물의 제조 방법
IL111029A (en) Esters of 4-hydroxyalkyl-indoline-2-helium
CZ283215B6 (cs) Způsob výroby 3-(alfa-methyxy)methylenbenzofuranonů
JP2001519353A (ja) ヒドロキシ酢酸エステル誘導体、その製法及び合成中間体としての用途
JP2846042B2 (ja) インドールカルボン酸誘導体の製造法
DK149230B (da) Analogifremgangsmaade til fremstilling af 5-benzoyl-6-hydroxy-indan-1-carboxylsyrederivater eller farmaceutisk acceptable salte deraf
Jackson et al. The synthesis of indolyl-butyric acid and some of its derivatives
JPH06179677A (ja) エセレトールからフィソスチグミンカルバメート誘導体を製造する方法
Hurd et al. Hydroxamic acids and N-hydroxyimides related to pyridine, pyrazine, and quinoxaline
NO157637B (no) Gelformig anode og elektrokjemisk celle inneholdende denne
US3933818A (en) Heterocyclic compounds
JP2622135B2 (ja) インデン誘導体及びその製造方法
US4042600A (en) Pyrolysis of 2-sulfochloride benzoates
EP0238411A1 (fr) Dihydro-1,2 méthyl-4 oxo-1 5-H pyrido (4,3-b) indoles et leur procédé de synthèse
NZ242374A (en) Phenyl alkyl ester compounds useful as intermediates in the preparation of 4-(aminoalkyl)-1,3-dihydro-2h-indol-2-one derivatives
US4216340A (en) Preparation of 5-(2,4-difluorophenyl)salicylic acid and derivatives
US3972883A (en) 1,6-Dimethyl-8β-[2' or 3'-pyrroyloxyethyl or substituted pyrroyloxyethyl]-10α-methoxyergolene compounds
JPS6350351B2 (fi)
JPH09176167A (ja) フィソスチグミンからフィソスチグミンカルバメート誘導体を製造する方法
IE42956B1 (en) 4-amino-3-pyrrole carboxamides
US5153330A (en) Thiapentanamide derivatives
US3551476A (en) 3-(hydroxyphenyl)-4-aminovalerates
SU528871A3 (ru) Способ получени производных 2-(1н) -хиназолинона
IT202100020591A1 (it) Preparazione di un intermedio di un agente per il trattamento dell'anemia
NO123526B (fi)

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
RH Patent void
KB Patent renewed
KB Patent renewed
KB Patent renewed
EXP Patent expired